Search by Drug Name or NDC

    NDC 42227-0083-01 Cinryze Details

    Cinryze

    Cinryze is a KIT in the PLASMA DERIVATIVE category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is .

    Product Information

    NDC 42227-0083
    Product ID 42227-083_696969cf-1588-4eec-9874-7de096db04dd
    Associated GPIs 85802022002120
    GCN Sequence Number 040429
    GCN Sequence Number Description C1 esterase inhibitor VIAL 500 (5 ML) INTRAVEN
    HIC3 M0N
    HIC3 Description C1 ESTERASE INHIBITORS
    GCN 10495
    HICL Sequence Number 018568
    HICL Sequence Number Description C1 ESTERASE INHIBITOR
    Brand/Generic Brand
    Proprietary Name Cinryze
    Proprietary Name Suffix n/a
    Non-Proprietary Name HUMAN C1-ESTERASE INHIBITOR
    Product Type PLASMA DERIVATIVE
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Takeda Pharmaceuticals America, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125267
    Listing Certified Through 2024-12-31

    Package

    NDC 42227-0083-01 (42227008301)

    NDC Package Code 42227-083-01
    Billing NDC 42227008301
    Package 1 KIT in 1 CARTON (42227-083-01) * 5 mL in 1 VIAL, SINGLE-USE (42227-081-01) * 5 mL in 1 VIAL, GLASS (64764-515-50)
    Marketing Start Date 2021-01-15
    NDC Exclude Flag N
    Pricing Information N/A